12 / 57 resources displayed
-
Fact Sheet
Translational Pharmaceutics
Translational Pharmaceutics innovates the way you design and implement your drug development program and is proven to reduce drug development costs and shorten timelines.
-
Webinar
Integrated Early-Stage Drug Development and Manufacturing: Accelerating Molecules to Proof-of-Concept
This webinar will highlight how by breaking down the barriers between traditional outsourcing channels and workflows, drug development activities and key functional groups including formulation development, manufacturing and clinical research can be much more closely integrated to accelerate early-stage drug development, reduce overall expenditure and shorten time to proof of concept.
-
Scientific Posters
An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675
The aim of the phase 1, single-center, randomized, active-controlled study in healthy volunteers reported in this paper was to investigate the pharmacodynamic effects and safety of different dosing regimens of RDX7675 in humans.
-
Fact Sheet
Formulation development
From preclinical and first-in-human (FIH) dosage forms to optimization of your drug products for late stage development, we work with you to develop the most appropriate formulation.
-
Fact Sheet
Clinical pharmacology
When you need a Phase I clinical pharmacology study, we can support you with rapid study startup and recruitment, and design a tailored program to meet the requirements of major regulatory agencies.
-
Fact Sheet
Pediatrics
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
-
Fact Sheet
First-in-Human to Proof-of-Concept
Our Translational Pharmaceutics approach enables First-in-Human studies by re-engineering the transition of your drug molecule into clinical development and shortening the timeline to Proof-of-Concept.
-
Fact Sheet
Partnering to accelerate pediatric drug development
Through our partnership with PPD, we can provide one solution to execute an entire pediatric program with the potential for one contract and a single point of contact.
-
Webinar
Considerations for First-In-Human Clinical Trials: Planning for Success
The First-in-human (FIH) clinical trial is a pivotal milestone in the drug development process and is the stage-gate before molecules can proceed to Phase II/proof of concept trials.
-
Webinar
Pharmaceutical Spray Drying to Overcome Poor Drug Solubility
Overcoming poor drug solubility is a common and challenging task facing the formulation scientist today.
-
Webinar
How to Reduce the Time and Cost for Optimizing Drug Product Formulations
Join industry experts John McDermott, Executive Director of Drug Product Optimization, and Kieran Crowley, Senior Scientific Director, both from Quotient Scienbces, as they outline studies and metrics in drug delivery and drug product optimization.
-
Webinar
Challenges and Opportunities in Pediatric Product Development
Over the last decade global regulatory bodies have increased the pressure on industry to develop authorized medicines for pediatric populations in order to improve and protect child health.